$GILD Recent Headlines Earnings boost Micron, drag on

New Post Public Reply Private Reply Replies (0) Message Board

Jan 9, 2014 at 11:55 AM

$GILD Recent Headlines

Earnings boost Micron, drag on Container Store 4:25 p.m. Jan. 8, 2014 - Sue Chang
Buying the 2014 recovery 12:01 a.m. Jan. 7, 2014 - Jim Lowell
Goldman's biotech downgrade and the new consensus 11:53 a.m. Jan. 6, 2014 - MarketWatch.com
3 top trades for 2014 6:01 a.m. Dec. 30, 2013 - Jeff Reeves
Investors warm up to Gilead's test results; shares climb 5% by close 4:49 p.m. Dec. 18, 2013 - Russ Britt
Twitter hits record; Campbell, Starbucks head south 4:25 p.m. Dec. 10, 2013 - Sue Chang
Speculators should retain a flexible approach 1:41 p.m. Dec. 4, 2013 - The Trading Deck
Nasdaq’s climb reflects vast shifts in global economy 10:19 a.m. Nov. 27, 2013 - Dan Strumpf
Nasdaq makes first close above 4,000 in 13 years: stock market live blog recap 5:03 p.m. Nov. 26, 2013 - blogs.marketwatch.com
AbbVie shares up on Hepatitis C results, but gains may be muted 11:49 a.m. Nov. 18, 2013 - Russ Britt
Dan Loeb ups stake in FedEx, Google, trims Yahoo 5:41 p.m. Nov. 14, 2013 - Sital S. Patel
Selling in growth-stock leaders continues 11:23 a.m. Oct. 31, 2013 - The Trading Deck
LinkedIn, Yelp decline; Baidu rallies after hours 5:14 p.m. Oct. 29, 2013 - Wallace Witkowski
Gilead profit up 17% as HIV drugs top sales growth 4:07 p.m. Oct. 29, 2013 - MarketWatch.com
Gilead shares rise 1% in late trading 3:59 p.m. Oct. 29, 2013 - Laura Mandaro
Earnings season focus shifts to revenue, capex 8:53 a.m. Oct. 27, 2013 - Wallace Witkowski
Healthcare stocks fall from first place in race for year's best-performing sector 2:32 p.m. Oct. 24, 2013 - blogs.marketwatch.com
In focus: Overbought conditions abound 7:21 p.m. Oct. 23, 2013 - Lawrence G. McMillan
Best Buy tops S&P 500; Netflix snaps losing streak 3:21 p.m. Oct. 10, 2013 - Sue Chang
Best Buy, Gilead Sciences lead S&P 500 gainers 3:05 p.m. Oct. 10, 2013 - Polya Lesova

Healthcare Picks By Drug Type In 2014 8:59 a.m. Today - Seeking Alpha
Nomura starts coverage on multiple biotechs 10:46 a.m. Jan. 8, 2014 - Seeking Alpha
J.P. Morgan Top Biotechnology Stocks to Buy for 2014 7:39 a.m. Jan. 8, 2014 - 247WallSt.com
Enanta Joins Big Leagues With Hepatitis C Drug 6:15 p.m. Jan. 7, 2014 - Investors Business Daily
Top Funds Like Facebook And Health Care Stocks 5:59 p.m. Jan. 7, 2014 - Investors Business Daily
Best Ideas for 2014 (Part 2) 3:29 p.m. Jan. 7, 2014 - RealMoney.com
Ascent of the Fallen Stars 2:24 p.m. Jan. 7, 2014 - Barrons.com
Is the Biotech Boom Over? 10:58 a.m. Jan. 7, 2014 - Barrons.com
Gilead VP of Commercial Operations to retire 7:34 a.m. Jan. 7, 2014 - Seeking Alpha
Gilead Sales Chief Retires Amidst Key Hep C Drug Launch, Massive Insider Selling 6:00 a.m. Jan. 7, 2014 - TheStreet.com
Jim Cramer's 'Mad Money' Recap: Profiting From Down Days 8:20 p.m. Jan. 6, 2014 - TheStreet.com
Market Hustle: Futures Rise Despite More China Weakness 9:01 a.m. Jan. 6, 2014 - TheStreet.com
The Gilead Rebuttal 8:38 a.m. Jan. 6, 2014 - Seeking Alpha
Citi's top biotech picks include Biogen, Gilead, and Celgene 8:33 a.m. Jan. 6, 2014 - Seeking Alpha
Positioning For 2014 In The Health Care Sector 8:04 a.m. Jan. 6, 2014 - Seeking Alpha
Analysts Issue Bullish Biotech Outlooks for '14, Except Goldman, Which Is Negative 6:03 a.m. Jan. 6, 2014 - TheStreet.com
My Best Ideas for (the Start of) 2014 6:00 p.m. Jan. 5, 2014 - RealMoney.com
Gilead’s Sovaldi Awarded Breakthrough Designation 10:14 a.m. Jan. 5, 2014 - Wall St. Cheat Sheet
Stocks Continue to Party 3:51 a.m. Jan. 4, 2014 - Barrons.com
Gilead maintained a Buy at Deutsche after latest data 2:21 p.m. Jan. 3, 2014 - Seeking Alpha

Retirement Announcements, Stock Price Movements, and Scheduled Conferences Presentations - Research Report on Gilead, Aegerion, Celldex, Alnylam, and Ironwood 8:00 a.m. Today - PR Newswire
Stock Price Movements, Conference Presentation Schedules, and Expanded Sharing of Clinical Data - Research Report on Gilead, Express Scripts, Sanofi, Agilent, and Kythera Biopharma 8:00 a.m. Jan. 8, 2014 - PR Newswire
Galectin Therapeutics Receives Patent for Combination Treatment for Liver Fibrosis 12:17 p.m. Jan. 7, 2014 - ACCESSWIRE
Notable Buzzers: Apple Inc, Stereotaxis Inc, Tiger Oil and Energy Inc, Gilead Sciences Inc 11:00 a.m. Jan. 7, 2014 - ACCESSWIRE
Gilead Sciences' Kevin Young CBE, Executive Vice President, Commercial Operations, to Retire 4:29 p.m. Jan. 6, 2014 - BusinessWire
Critical Alerts For Trina Solar, Gilead Sciences, Priceline, Akamai, and Anglogold Ashanti Released By InvestorsObserver 9:31 a.m. Jan. 2, 2014 - PR Newswire
Technical Briefing on Health Care Sector: Gilead Sciences, Halozyme Therapeutics, NPS Pharma, and InterMune 8:00 a.m. Dec. 26, 2013 - PR Newswire
Clinical Trial Results, Stock Movements, Grants & Donations, and Drug Resubmissions - Research Report on Gilead, WellPoint, Zoetis, Teleflex, and Orexigen 8:00 a.m. Dec. 23, 2013 - PR Newswire
Obesity Stock Plays Standing Out from the Crowd 10:04 a.m. Dec. 20, 2013 - ACCESSWIRE
Gilead Sciences Tops List of California's Most Honored Companies in Institutional Investor's All-America Executive Team Ranking 8:00 a.m. Dec. 19, 2013 - Marketwire
Gilead Announces SVR12 Rates From Three Phase 3 Studies Evaluating a Once-Daily Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients 8:30 a.m. Dec. 18, 2013 - BusinessWire
FDA Consents, Pending Acquisition Approvals, Program Deployments, and Stock Movements - Research Report on Gilead, Elan, Agilent, Alkermes and Hospira 8:00 a.m. Dec. 18, 2013 - PR Newswire
Critical Insider Analysis: MGM Resorts International, Groupon Inc, Gilead Sciences, Barrick Gold Corporation 9:30 a.m. Dec. 17, 2013 - ACCESSWIRE
FDA Approvals, Dividends, Promoting Diversity, Result Publications and Acquisitions - Research Report on Gilead, St. Jude Medical, Cigna, Pharmacyclics, and LifePoint 8:00 a.m. Dec. 17, 2013 - PR Newswire
Health Canada Issues Notice of Compliance for Sovaldi(TM) (Sofosbuvir) for the Treatment of Chronic Hepatitis C 8:30 a.m. Dec. 16, 2013 - BusinessWire
U.S. FDA Approves Gilead's Once-Daily Single Tablet HIV-1 Regimen Complera(R) for Patients Switching from a Stable Regimen 4:30 p.m. Dec. 13, 2013 - BusinessWire
HealthStat Rx: Curing Hepatitis C (HCV) With Confidence 10:07 a.m. Dec. 12, 2013 - BusinessWire
Here to Track Insider Trading of Gilead Sciences, Microsoft, Halliburton 8:55 a.m. Dec. 11, 2013 - PR Newswire
Clinical Study Results, Stock Price Movements, and Acquisitions - Research Report on Gilead, Life Technologies, Jazz Pharmaceuticals, CSI, and Smith & Nephew 8:00 a.m. Dec. 11, 2013 - PR Newswire
Final Hour Buzz: Gilead Sciences, MannKind Corporation, Facebook Inc, Tiger Oil and Energy 2:46 p.m. Dec. 10, 2013 - ACCESSWIRE

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

AEVEX Faces $100K+ Losses in New Investor Lawsuit

When the suits start flying, folks, you know there's a mess brewing somewhere in the market. Here we are, talking about AEVEX Corp, ticker NYSE:AVEX, and they’re facing some serious heat. There's some scuttlebutt about a class action lawsuit that’s got investors clutching onto their wallets tighter than ever. If you’ve been scouring over the papers, this lawsuit is...

Morpho Unveils Versatile UV Printer at IFA 2026

IFA 2026: A New Frontier for Desktop Printing You've seen your fair share of printers over the years, but when a company like Morpho steps onto the scene with a gadget that echoes innovation, it makes you perk up those market-ears. We're talking the big unveil of their desktop UV printer at the IFA 2026 in Berlin. Morpho's contraption isn't just spewing out ink; it's...

LiberNovo Demos Ergonomic Seating at IFA 2026

Riding the Ergonomic Wave at IFA 2026 No stranger to the innovation spotlight, LiberNovo’s got its eyes on Berlin this time around. As sparks fly at the IFA 2026, they’re rolling out their grand Maxis Series and rubbing shoulders with big names in technology. How does a company shake things up in a sea of tech? Start by thinking big and tall—literally. Maxis Series:...

Postal Service Defends New Rule Amid Speculation

USPS Navigates Election Mail Controversies The U.S. Postal Service has found itself in the eye of a political storm, thanks to the latest Federal Ballot Mail Rule. Led by Postmaster General David Steiner, the USPS is setting the record straight amidst swirling misinformation and skepticism about its recent actions. This is not just a postal service under scrutiny—it's a...

Virterion Surges Ahead in VPS Racing With Reliable Hosting

Why Virterion Stands Out in 2026 VPS Landscape For anyone knee-deep in the hosting game, you know the market's got more players than a late-night poker round. Virterion, though—that's a name carving out a noticeable niche, and for solid reasons. In 2026, the backdrop's not just speed, it’s about matching technology and support with what ambitious developers need. VPS...

viaim's AI Earbuds Snag IFA Awards, Launch On Indiegogo

When the tech cosmos hands you two hefty IFA Innovation Awards, you know you’re onto something. viaim’s Rise wasn't just about slick marketing—it brought home the 'Best in Audio' and 'Best in Design' titles from IFA 2026, proving these earbuds are more than just another gadget. Key Innovations Behind the Accolades IFA is no small affair—it's a major tech trade...

Sarepta Under Scrutiny: KSF's Investigation Deepens

A Troubling Chapter for Sarepta Therapeutics It's not every day that a company's dirty laundry gets hung out for all to see, especially when we're talking about Sarepta Therapeutics, a player in the rare disease treatment space. But that's exactly where we find ourselves this fine day—a bit like kicking a hornet's nest, if you ask me. Led by the former Louisiana...

ToolDance X1 CNC Mill Unveils at IFA 2026

IFA 2026 Reveals a Game Changer: ToolDance X1 Listen up, because ToolDance just threw a curveball into the CNC world with the launch of their X1 Smart Desktop CNC Mill at the IFA 2026 in Berlin. This isn't just another gadget—it's a real player aiming to bring manufacturing muscle right to your desktop. Will Wang, the genius behind ToolDance, wants to democratize CNC...

Tuya Smart's AI Innovations Steal the Spotlight at IFA

AI Taking Center Stage at IFA 2026 Amidst the chaos of tech exhibitions, something caught my attention—Tuya Smart's push in making AI a household name. Now, you might wonder why I’m bringing this up. Well, because it's not your typical flashy gadget talk. This is about Tuya parading their latest breakthroughs like a peacock at the world's stage, IFA 2026 in Berlin,...

SIAL West Asia Ignites Global F&B Trade at Guangzhou

A Convergence of Global Taste You could feel the buzz in the air as the 2026 SIAL West Asia International Food Exhibition kicked off at the Guangzhou Poly World Trade Center Expo. Throw over 1,500 exhibitors from the far corners of the globe into a sprawling 60,000-square-meter trade floor, and you've got yourself a melting pot of flavors and cultures revolving around a...